Angola Reports Over 20,000 Cholera Cases Since January Amid Outbreak

Angola reports over 20,000 cholera cases with more than 600 fatalities since January, highlighting ongoing public health challenges due to poor sanitation and water safety.
Since the beginning of the year, Angola has experienced a significant cholera outbreak, surpassing 20,000 confirmed cases and resulting in more than 600 deaths, according to the country's health ministry. The recent daily report indicated that 20,050 cases have been recorded, with 612 fatalities. In the past 24 hours alone, there have been 233 new cases and three deaths. The outbreak primarily affects urban areas, with around one-third of cases concentrated in Luanda province, the capital. The affected individuals range from as young as two years old to centenarians. Cholera, an acute diarrheal disease caused by the bacterium Vibrio cholerae, spreads mainly through contaminated water and food. It leads to severe dehydration, diarrhea, vomiting, and muscle cramps, which can result in death within hours if not promptly treated through oral rehydration and antibiotics. Despite Angola's substantial oil wealth, ongoing challenges related to poor sanitation and infrastructure have facilitated recurrent cholera outbreaks, especially during the rainy season. The current outbreak began in January and has rapidly expanded across most of the country's 21 provinces, emphasizing the urgent need for improved sanitation measures and access to clean water. This persistent health crisis underscores the importance of strengthening public health responses to prevent future outbreaks.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Exercise MRI Technique Enhances Heart Disease Diagnosis
A new exercise-based MRI technique allows clinicians to observe real-time heart responses during physical activity, facilitating earlier and more accurate diagnosis of heart disease.
Can Vitamin D Supplements Help Slow the Aging Process?
Emerging research suggests that daily vitamin D supplements may help protect telomeres, the key to cellular aging, potentially supporting healthier and longer lives. Learn more about the recent findings and their implications for aging.
FDA Approves Zynyz as First-Line Therapy for Advanced Anal Cancer
The FDA has approved Zynyz, a PD-1 inhibitor, as the first-line treatment for advanced anal cancer, offering new hope for patients with limited options and demonstrating significant clinical benefits based on recent trial results.



